(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of FBXO32 mRNA] CTD PMID:31150632 (S)-(-)-perillyl alcohol increases expression ISO RGD:737552 6480464 perillyl alcohol results in increased expression of FBXO32 mRNA, perillyl alcohol results in increased expression of FBXO32 protein CTD PMID:19406843 1,2-dichloroethane decreases expression ISO RGD:737552 6480464 ethylene dichloride results in decreased expression of FBXO32 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:737552 6480464 1, 2-Dimethylhydrazine results in decreased expression of FBXO32 mRNA CTD PMID:22206623 17beta-estradiol increases expression ISO RGD:734419 6480464 Estradiol results in increased expression of FBXO32 mRNA CTD PMID:16474171 17beta-estradiol decreases expression ISO RGD:734419 6480464 Estradiol results in decreased expression of FBXO32 mRNA CTD PMID:24758408 , PMID:31614463 17beta-estradiol multiple interactions ISO RGD:734419 6480464 [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of FBXO32 mRNA more ... CTD PMID:23275455 , PMID:24758408 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:734419 6480464 Tetrachlorodibenzodioxin results in decreased expression of FBXO32 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of FBXO32 mRNA CTD PMID:33387578 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:734419 6480464 Tetrachlorodibenzodioxin results in increased expression of FBXO32 mRNA CTD PMID:30096437 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:737552 6480464 Tetrachlorodibenzodioxin affects the expression of FBXO32 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:737552 6480464 Tetrachlorodibenzodioxin results in increased expression of FBXO32 mRNA CTD PMID:19933214 2-butoxyethanol decreases expression ISO RGD:737552 6480464 n-butoxyethanol results in decreased expression of FBXO32 mRNA CTD PMID:19812364 2-hydroxypropanoic acid decreases expression ISO RGD:734419 6480464 Lactic Acid results in decreased expression of FBXO32 mRNA CTD PMID:30851411 2-trans,6-trans,10-trans-geranylgeranyl diphosphate multiple interactions ISO RGD:737552 6480464 geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of FBXO32 mRNA], geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of FBXO32 protein] CTD PMID:19406843 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:737552 6480464 tetrabromobisphenol A results in decreased expression of FBXO32 mRNA CTD PMID:25172293 3,4-methylenedioxymethamphetamine increases expression ISO RGD:737552 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of FBXO32 mRNA CTD PMID:20188158 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of FBXO32 mRNA CTD PMID:28522335 3-hydroxyisovaleric acid increases expression EXP 6480464 beta-hydroxyisovaleric acid results in increased expression of FBXO32 mRNA CTD PMID:24124592 3-hydroxyisovaleric acid multiple interactions EXP 6480464 beta-hydroxyisovaleric acid inhibits the reaction [Dexamethasone results in increased expression of FBXO32 mRNA] CTD PMID:24124592 4,4'-diaminodiphenylmethane decreases expression ISO RGD:737552 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of FBXO32 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:737552 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of FBXO32 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression ISO RGD:737552 6480464 Fenretinide results in increased expression of FBXO32 mRNA CTD PMID:28973697 4-nitrophenol decreases expression ISO RGD:737552 6480464 4-nitrophenol results in decreased expression of FBXO32 mRNA CTD PMID:34673133 4-phenylbutyric acid multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of FBXO32 protein] CTD PMID:30980806 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide multiple interactions ISO RGD:734419 6480464 [6-chloro-2 more ... CTD PMID:22146233 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of FBXO32 mRNA CTD PMID:24780913 6alpha-methylprednisolone increases expression EXP 6480464 Methylprednisolone results in increased expression of FBXO32 protein CTD PMID:21931329 6alpha-methylprednisolone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Methylprednisolone results in increased expression of FBXO32 protein] CTD PMID:21931329 8-Br-cAMP multiple interactions ISO RGD:734419 6480464 [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of FBXO32 mRNA, NR3C2 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of FBXO32 mRNA] CTD PMID:23275455 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of FBXO32 mRNA CTD PMID:31881176 aflatoxin B1 decreases expression ISO RGD:734419 6480464 Aflatoxin B1 results in decreased expression of FBXO32 mRNA CTD PMID:22100608 aflatoxin B1 increases methylation ISO RGD:734419 6480464 Aflatoxin B1 results in increased methylation of FBXO32 gene CTD PMID:27153756 aldehydo-D-glucose multiple interactions ISO RGD:737552 6480464 FBXO32 protein affects the reaction [Glucose results in decreased expression of KCNN2 protein] CTD PMID:30635400 aldehydo-D-glucose increases expression ISO RGD:737552 6480464 Glucose results in increased expression of FBXO32 protein CTD PMID:30635400 amiodarone increases expression ISO RGD:734419 6480464 Amiodarone results in increased expression of FBXO32 mRNA CTD PMID:19774075 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of FBXO32 mRNA CTD PMID:16483693 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of FBXO32 mRNA CTD PMID:30779732 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:737552 6480464 pyrazolanthrone inhibits the reaction [Indican results in increased expression of FBXO32 protein] CTD PMID:30849338 aristolochic acid A increases expression ISO RGD:734419 6480464 aristolochic acid I results in increased expression of FBXO32 mRNA CTD PMID:33212167 arotinoid acid multiple interactions ISO RGD:734419 6480464 [4-(2-(5 more ... CTD PMID:34480604 arsane affects expression ISO RGD:734419 6480464 Arsenic affects the expression of FBXO32 mRNA CTD PMID:18414638 arsane multiple interactions ISO RGD:734419 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of FBXO32 mRNA CTD PMID:32525701 arsane affects methylation ISO RGD:734419 6480464 Arsenic affects the methylation of FBXO32 gene CTD PMID:25304211 arsenic atom affects expression ISO RGD:734419 6480464 Arsenic affects the expression of FBXO32 mRNA CTD PMID:18414638 arsenic atom multiple interactions ISO RGD:734419 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of FBXO32 mRNA CTD PMID:32525701 arsenic atom affects methylation ISO RGD:734419 6480464 Arsenic affects the methylation of FBXO32 gene CTD PMID:25304211 arsenous acid increases expression ISO RGD:737552 6480464 Arsenic Trioxide results in increased expression of FBXO32 protein CTD PMID:32184170 , PMID:32635466 arsenous acid increases expression ISO RGD:734419 6480464 Arsenic Trioxide results in increased expression of FBXO32 mRNA CTD PMID:24356939 atorvastatin calcium increases expression EXP 6480464 Atorvastatin results in increased expression of FBXO32 mRNA CTD PMID:27377005 avobenzone increases expression ISO RGD:734419 6480464 avobenzone results in increased expression of FBXO32 mRNA CTD PMID:31016361 benzo[a]pyrene decreases expression ISO RGD:734419 6480464 Benzo(a)pyrene results in decreased expression of FBXO32 mRNA CTD PMID:20106945 benzo[a]pyrene decreases methylation ISO RGD:734419 6480464 Benzo(a)pyrene results in decreased methylation of FBXO32 5' UTR CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:734419 6480464 Benzo(a)pyrene results in increased methylation of FBXO32 3' UTR, Benzo(a)pyrene results in increased methylation of FBXO32 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:737552 6480464 Benzo(a)pyrene results in decreased expression of FBXO32 mRNA CTD PMID:22228805 benzo[a]pyrene increases expression ISO RGD:737552 6480464 Benzo(a)pyrene results in increased expression of FBXO32 mRNA CTD PMID:21715664 bis(2-chloroethyl) sulfide increases expression ISO RGD:734419 6480464 Mustard Gas results in increased expression of FBXO32 mRNA CTD PMID:25102026 bisphenol A increases expression ISO RGD:737552 6480464 bisphenol A results in increased expression of FBXO32 mRNA CTD PMID:26063408 bisphenol A multiple interactions ISO RGD:734419 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of FBXO32 gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FBXO32 mRNA CTD PMID:30816183 , PMID:32528016 bisphenol A increases expression ISO RGD:734419 6480464 bisphenol A results in increased expression of FBXO32 mRNA CTD PMID:16474171 more ... Botulinum toxin type A multiple interactions ISO RGD:737552 6480464 Ouabain affects the reaction [Botulinum Toxins, Type A affects the expression of FBXO32 mRNA] CTD PMID:21139329 Botulinum toxin type A affects expression ISO RGD:737552 6480464 Botulinum Toxins, Type A affects the expression of FBXO32 mRNA CTD PMID:21139329 calcitriol decreases expression ISO RGD:734419 6480464 Calcitriol results in decreased expression of FBXO32 mRNA CTD PMID:16002434 calcitriol multiple interactions ISO RGD:737552 6480464 Calcitriol inhibits the reaction [Dexamethasone results in increased expression of FBXO32 mRNA] CTD PMID:29962435 cannabidiol increases expression ISO RGD:734419 6480464 Cannabidiol results in increased expression of FBXO32 mRNA CTD PMID:26504004 cannabidiol multiple interactions ISO RGD:734419 6480464 [Dronabinol co-treated with Cannabidiol] results in increased expression of FBXO32 mRNA CTD PMID:26504004 carbon nanotube affects expression ISO RGD:737552 6480464 Nanotubes, Carbon analog affects the expression of FBXO32 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:737552 6480464 Nanotubes, Carbon results in decreased expression of FBXO32 mRNA CTD PMID:25554681 carmustine affects response to substance ISO RGD:734419 6480464 FBXO32 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 celastrol decreases expression EXP 6480464 celastrol results in decreased expression of FBXO32 protein CTD PMID:25903958 celastrol multiple interactions EXP 6480464 HSPA1A protein affects the reaction [celastrol results in decreased expression of FBXO32 protein] CTD PMID:25903958 CGP 52608 multiple interactions ISO RGD:734419 6480464 CGP 52608 promotes the reaction [RORA protein binds to FBXO32 gene] CTD PMID:28238834 CHIR 99021 decreases expression ISO RGD:737552 6480464 Chir 99021 results in decreased expression of FBXO32 mRNA CTD PMID:21832246 CHIR 99021 multiple interactions ISO RGD:734419 6480464 [4-(2-(5 more ... CTD PMID:34480604 CHIR 99021 multiple interactions ISO RGD:737552 6480464 Chir 99021 inhibits the reaction [Dexamethasone results in increased expression of FBXO32 mRNA] CTD PMID:21832246 chlordecone increases expression ISO RGD:737552 6480464 Chlordecone results in increased expression of FBXO32 mRNA CTD PMID:33711761 chloroquine affects expression EXP 6480464 Chloroquine affects the expression of FBXO32 mRNA CTD PMID:19296457 choline multiple interactions ISO RGD:737552 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FBXO32 mRNA CTD PMID:20938992 chromium atom decreases expression EXP 6480464 Chromium deficiency results in decreased expression of FBXO32 mRNA, Chromium results in decreased expression of FBXO32 protein CTD PMID:19071005 , PMID:20404053 cisplatin increases expression ISO RGD:737552 6480464 Cisplatin results in increased expression of FBXO32, Cisplatin results in increased expression of FBXO32 mRNA CTD PMID:21074548 more ... cobalt dichloride increases expression ISO RGD:737552 6480464 cobaltous chloride results in increased expression of FBXO32 protein CTD PMID:23684559 copper(II) sulfate increases expression ISO RGD:734419 6480464 Copper Sulfate results in increased expression of FBXO32 mRNA CTD PMID:19549813 cortisol multiple interactions ISO RGD:734419 6480464 [4-(2-(5 more ... CTD PMID:34480604 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of FBXO32 mRNA CTD PMID:27523638 cyclosporin A increases expression ISO RGD:734419 6480464 Cyclosporine results in increased expression of FBXO32 mRNA CTD PMID:25562108 , PMID:27989131 D-glucose increases expression ISO RGD:737552 6480464 Glucose results in increased expression of FBXO32 protein CTD PMID:30635400 D-glucose multiple interactions ISO RGD:737552 6480464 FBXO32 protein affects the reaction [Glucose results in decreased expression of KCNN2 protein] CTD PMID:30635400 DDT decreases expression EXP 6480464 DDT results in decreased expression of FBXO32 mRNA CTD PMID:30207508 dexamethasone multiple interactions ISO RGD:737552 6480464 (+)-JQ1 compound inhibits the reaction [Dexamethasone results in increased expression of FBXO32 mRNA] more ... CTD PMID:19032942 more ... dexamethasone increases expression ISO RGD:737552 6480464 Dexamethasone results in increased expression of FBXO32 mRNA, Dexamethasone results in increased expression of FBXO32 protein CTD PMID:19032942 more ... dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of FBXO32 mRNA CTD PMID:18436443 , PMID:24124592 dexamethasone multiple interactions EXP 6480464 beta-hydroxyisovaleric acid inhibits the reaction [Dexamethasone results in increased expression of FBXO32 mRNA], Testosterone inhibits the reaction [Dexamethasone results in increased expression of FBXO32 mRNA] CTD PMID:18436443 , PMID:24124592 diarsenic trioxide increases expression ISO RGD:737552 6480464 Arsenic Trioxide results in increased expression of FBXO32 protein CTD PMID:32184170 , PMID:32635466 diarsenic trioxide increases expression ISO RGD:734419 6480464 Arsenic Trioxide results in increased expression of FBXO32 mRNA CTD PMID:24356939 diazinon increases methylation ISO RGD:734419 6480464 Diazinon results in increased methylation of FBXO32 gene CTD PMID:22964155 dibutyl phthalate decreases expression ISO RGD:737552 6480464 Dibutyl Phthalate results in decreased expression of FBXO32 mRNA CTD PMID:21266533 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of FBXO32 mRNA CTD PMID:21266533 dioxygen increases expression ISO RGD:737552 6480464 Oxygen deficiency results in increased expression of FBXO32 mRNA CTD PMID:23624791 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of FBXO32 mRNA CTD PMID:33729688 dioxygen multiple interactions ISO RGD:737552 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FBXO32 mRNA CTD PMID:30529165 dioxygen increases expression ISO RGD:734419 6480464 Oxygen deficiency results in increased expression of FBXO32 mRNA CTD PMID:26516004 disodium selenite increases expression ISO RGD:734419 6480464 Sodium Selenite results in increased expression of FBXO32 mRNA CTD PMID:18175754 , PMID:24383545 doxorubicin multiple interactions EXP 6480464 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Doxorubicin results in increased expression of FBXO32 mRNA], AKT1 protein inhibits the reaction [Doxorubicin results in increased expression of FBXO32 mRNA] CTD PMID:18346979 doxorubicin increases expression ISO RGD:734419 6480464 Doxorubicin results in increased expression of FBXO32 mRNA CTD PMID:29803840 doxorubicin affects expression ISO RGD:734419 6480464 Doxorubicin affects the expression of FBXO32 mRNA CTD PMID:25529476 doxorubicin increases expression ISO RGD:737552 6480464 Doxorubicin results in increased expression of FBXO32 mRNA, Doxorubicin results in increased expression of FBXO32 protein CTD PMID:23639627 , PMID:25896364 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of FBXO32 mRNA, Doxorubicin results in increased expression of FBXO32 protein CTD PMID:18346979 , PMID:23639627 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of FBXO32 mRNA CTD PMID:29391264 ethanol affects splicing ISO RGD:737552 6480464 Ethanol affects the splicing of FBXO32 mRNA CTD PMID:30319688 fenofibrate multiple interactions ISO RGD:737552 6480464 Lovastatin promotes the reaction [Fenofibrate results in increased expression of FBXO32 protein], PPARA protein affects the reaction [Fenofibrate results in increased expression of FBXO32 mRNA] CTD PMID:33408297 fenofibrate increases expression ISO RGD:737552 6480464 Fenofibrate results in increased expression of FBXO32 mRNA, Fenofibrate results in increased expression of FBXO32 protein CTD PMID:33408297 fluoranthene multiple interactions ISO RGD:737552 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of FBXO32 mRNA CTD PMID:28329830 folic acid multiple interactions ISO RGD:737552 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FBXO32 mRNA CTD PMID:20938992 fulvestrant multiple interactions ISO RGD:734419 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of FBXO32 gene CTD PMID:31601247 gamma-hexachlorocyclohexane increases expression ISO RGD:734419 6480464 Hexachlorocyclohexane results in increased expression of FBXO32 mRNA CTD PMID:24356939 genistein increases expression ISO RGD:734419 6480464 Genistein results in increased expression of FBXO32 mRNA CTD PMID:16474171 glucose multiple interactions ISO RGD:737552 6480464 FBXO32 protein affects the reaction [Glucose results in decreased expression of KCNN2 protein] CTD PMID:30635400 glucose increases expression ISO RGD:737552 6480464 Glucose results in increased expression of FBXO32 protein CTD PMID:30635400 hexadecanoic acid increases expression ISO RGD:737552 6480464 Palmitic Acid results in increased expression of FBXO32 mRNA CTD PMID:25614714 hexadecanoic acid multiple interactions ISO RGD:737552 6480464 Quercetin inhibits the reaction [Palmitic Acid results in increased expression of FBXO32 mRNA] CTD PMID:25614714 indoxyl sulfate multiple interactions ISO RGD:737552 6480464 Acetylcysteine inhibits the reaction [Indican results in increased expression of FBXO32 protein], pyrazolanthrone inhibits the reaction [Indican results in increased expression of FBXO32 protein] CTD PMID:30849338 indoxyl sulfate increases expression ISO RGD:737552 6480464 Indican results in increased expression of FBXO32 mRNA, Indican results in increased expression of FBXO32 protein CTD PMID:29380555 , PMID:30849338 isoprenaline increases expression ISO RGD:737552 6480464 Isoproterenol results in increased expression of FBXO32 mRNA CTD PMID:20003209 L-ascorbic acid multiple interactions ISO RGD:734419 6480464 [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FBXO32 mRNA CTD PMID:34480604 L-ascorbic acid 2-phosphate multiple interactions ISO RGD:734419 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FBXO32 mRNA CTD PMID:34480604 L-methionine multiple interactions ISO RGD:737552 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FBXO32 mRNA CTD PMID:20938992 lead diacetate increases expression ISO RGD:737552 6480464 lead acetate results in increased expression of FBXO32 mRNA CTD PMID:20542052 Licochalcone B increases expression ISO RGD:734419 6480464 licochalcone B results in increased expression of FBXO32 mRNA CTD PMID:33647349 lipopolysaccharide increases expression ISO RGD:737552 6480464 Lipopolysaccharides results in increased expression of FBXO32 mRNA CTD PMID:17131360 lithium chloride decreases expression ISO RGD:737552 6480464 Lithium Chloride results in decreased expression of FBXO32 mRNA CTD PMID:21832246 lovastatin multiple interactions ISO RGD:737552 6480464 geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of FBXO32 mRNA] more ... CTD PMID:19406843 , PMID:33408297 lovastatin increases expression ISO RGD:737552 6480464 Lovastatin results in increased expression of FBXO32 mRNA, Lovastatin results in increased expression of FBXO32 protein CTD PMID:19406843 LY294002 decreases expression ISO RGD:737552 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of FBXO32 mRNA CTD PMID:21832246 metformin decreases expression EXP 6480464 Metformin results in decreased expression of FBXO32 mRNA CTD PMID:31324951 methamphetamine increases expression ISO RGD:737552 6480464 Methamphetamine results in increased expression of FBXO32 mRNA CTD PMID:23933405 methylmercury chloride increases expression ISO RGD:734419 6480464 methylmercuric chloride results in increased expression of FBXO32 mRNA CTD PMID:28001369 mevalonic acid multiple interactions ISO RGD:737552 6480464 Mevalonic Acid inhibits the reaction [Lovastatin results in increased expression of FBXO32 mRNA], Mevalonic Acid inhibits the reaction [Lovastatin results in increased expression of FBXO32 protein] CTD PMID:19406843 monocrotaline multiple interactions EXP 6480464 resveratrol inhibits the reaction [Monocrotaline results in decreased expression of FBXO32 mRNA] CTD PMID:22146233 monocrotaline increases expression EXP 6480464 Monocrotaline results in increased expression of FBXO32 mRNA CTD PMID:18801959 monocrotaline decreases expression EXP 6480464 Monocrotaline results in decreased expression of FBXO32 mRNA CTD PMID:22146233 Muraglitazar decreases expression EXP 6480464 muraglitazar results in decreased expression of FBXO32 mRNA CTD PMID:21515302 N-acetyl-L-cysteine multiple interactions ISO RGD:737552 6480464 Acetylcysteine inhibits the reaction [Indican results in increased expression of FBXO32 protein] CTD PMID:30849338 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:737552 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [FBXO32 protein results in decreased expression of KCNN2 protein] CTD PMID:30635400 nickel atom decreases expression ISO RGD:734419 6480464 Nickel results in decreased expression of FBXO32 mRNA CTD PMID:24768652 nickel dichloride increases expression ISO RGD:734419 6480464 nickel chloride results in increased expression of FBXO32 mRNA CTD PMID:21455298 nickel sulfate increases expression ISO RGD:734419 6480464 nickel sulfate results in increased expression of FBXO32 mRNA CTD PMID:22714537 ochratoxin A decreases expression ISO RGD:734419 6480464 ochratoxin A metabolite results in decreased expression of FBXO32 mRNA CTD PMID:24356939 ouabain multiple interactions ISO RGD:737552 6480464 Ouabain affects the reaction [Botulinum Toxins, Type A affects the expression of FBXO32 mRNA] CTD PMID:21139329 perfluorohexanesulfonic acid decreases expression ISO RGD:734419 6480464 perfluorohexanesulfonic acid results in decreased expression of FBXO32 mRNA CTD PMID:25812627 perfluorononanoic acid decreases expression ISO RGD:734419 6480464 perfluoro-n-nonanoic acid results in decreased expression of FBXO32 mRNA CTD PMID:25812627 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:734419 6480464 perfluorooctane sulfonic acid results in decreased expression of FBXO32 mRNA CTD PMID:25812627 perfluorooctanoic acid decreases expression ISO RGD:734419 6480464 perfluorooctanoic acid results in decreased expression of FBXO32 mRNA CTD PMID:25812627 perillyl alcohol increases expression ISO RGD:737552 6480464 perillyl alcohol results in increased expression of FBXO32 mRNA, perillyl alcohol results in increased expression of FBXO32 protein CTD PMID:19406843 phenethyl isothiocyanate increases expression ISO RGD:734419 6480464 phenethyl isothiocyanate results in increased expression of FBXO32 mRNA CTD PMID:26678675 phenobarbital affects expression ISO RGD:734419 6480464 Phenobarbital affects the expression of FBXO32 mRNA CTD PMID:19159669 potassium chromate decreases expression ISO RGD:734419 6480464 potassium chromate(VI) results in decreased expression of FBXO32 mRNA CTD PMID:22714537 progesterone multiple interactions ISO RGD:734419 6480464 [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of FBXO32 mRNA, NR3C2 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of FBXO32 mRNA] CTD PMID:23275455 quercetin multiple interactions ISO RGD:737552 6480464 Quercetin inhibits the reaction [Dietary Fats results in increased expression of FBXO32 mRNA], Quercetin inhibits the reaction [Palmitic Acid results in increased expression of FBXO32 mRNA] CTD PMID:25614714 rac-lactic acid decreases expression ISO RGD:734419 6480464 Lactic Acid results in decreased expression of FBXO32 mRNA CTD PMID:30851411 resveratrol multiple interactions EXP 6480464 [resveratrol results in increased localization of and results in increased activity of FOXO1 protein] which results in increased expression of FBXO32 mRNA, resveratrol inhibits the reaction [Monocrotaline results in decreased expression of FBXO32 mRNA] CTD PMID:18077353 , PMID:22146233 resveratrol multiple interactions ISO RGD:737552 6480464 FOXO1 protein promotes the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of FBXO32 mRNA]] more ... CTD PMID:24534773 resveratrol decreases expression ISO RGD:734419 6480464 resveratrol results in decreased expression of FBXO32 mRNA CTD PMID:25888808 resveratrol increases expression ISO RGD:734419 6480464 resveratrol results in increased expression of FBXO32 mRNA CTD PMID:22146233 SB 431542 multiple interactions ISO RGD:734419 6480464 [LDN 193189 co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of FBXO32 mRNA CTD PMID:34480604 simvastatin increases expression ISO RGD:737552 6480464 Simvastatin results in increased expression of FBXO32 mRNA, Simvastatin results in increased expression of FBXO32 protein CTD PMID:25300705 more ... simvastatin multiple interactions ISO RGD:737552 6480464 FST protein inhibits the reaction [Simvastatin results in increased expression of FBXO32 mRNA] more ... CTD PMID:27734117 , PMID:33034787 simvastatin increases expression EXP 6480464 Simvastatin results in increased expression of FBXO32 mRNA CTD PMID:19001041 , PMID:25300705 sirolimus multiple interactions ISO RGD:734419 6480464 [(+)-JQ1 compound co-treated with Sirolimus] affects the expression of FBXO32 mRNA, Sirolimus inhibits the reaction [TP73 protein results in increased expression of FBXO32 mRNA] CTD PMID:21245298 , PMID:25307878 sirolimus increases expression ISO RGD:734419 6480464 Sirolimus results in increased expression of FBXO32 mRNA CTD PMID:24356939 sirtinol multiple interactions ISO RGD:734419 6480464 [sirtinol results in decreased activity of SIRT1 protein] which results in decreased expression of FBXO32 mRNA CTD PMID:22146233 sodium arsenate increases expression ISO RGD:737552 6480464 sodium arsenate results in increased expression of FBXO32 mRNA CTD PMID:21795629 sodium arsenate multiple interactions ISO RGD:734419 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of FBXO32 mRNA CTD PMID:32525701 sodium arsenite increases expression ISO RGD:734419 6480464 sodium arsenite results in increased expression of FBXO32 mRNA CTD PMID:22714537 , PMID:23876855 sodium arsenite decreases expression ISO RGD:734419 6480464 sodium arsenite results in decreased expression of FBXO32 mRNA CTD PMID:34032870 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of FBXO32 protein CTD PMID:30980806 streptozocin increases expression ISO RGD:737552 6480464 Streptozocin results in increased expression of FBXO32 protein CTD PMID:30635400 streptozocin multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of FBXO32 protein] CTD PMID:30980806 sulforaphane decreases expression ISO RGD:734419 6480464 sulforaphane results in decreased expression of FBXO32 mRNA CTD PMID:31838189 sunitinib increases expression ISO RGD:737552 6480464 Sunitinib results in increased expression of FBXO32 mRNA CTD PMID:31445075 sunitinib increases expression ISO RGD:734419 6480464 Sunitinib results in increased expression of FBXO32 mRNA CTD PMID:31533062 temozolomide affects response to substance ISO RGD:734419 6480464 FBXO32 mRNA affects the susceptibility to temozolomide CTD PMID:16365179 temozolomide increases expression ISO RGD:734419 6480464 Temozolomide results in increased expression of FBXO32 mRNA CTD PMID:31758290 Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of FBXO32 mRNA CTD PMID:21515302 testosterone affects expression ISO RGD:737552 6480464 Testosterone affects the expression of FBXO32 mRNA CTD PMID:20403060 testosterone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of FBXO32 mRNA], Testosterone inhibits the reaction [Methylprednisolone results in increased expression of FBXO32 protein] CTD PMID:18436443 , PMID:21931329 testosterone increases expression EXP 6480464 Testosterone deficiency results in increased expression of FBXO32 mRNA, Testosterone deficiency results in increased expression of FBXO32 protein CTD PMID:19926828 testosterone multiple interactions ISO RGD:737552 6480464 Testosterone inhibits the reaction [Testosterone deficiency results in increased expression of FBXO32 mRNA] CTD PMID:21045173 testosterone increases expression ISO RGD:737552 6480464 Testosterone deficiency results in increased expression of FBXO32 mRNA, Testosterone results in increased expression of FBXO32 mRNA CTD PMID:20403060 , PMID:21045173 tetrachloro-1,4-benzoquinone increases expression ISO RGD:734419 6480464 Chloranil results in increased expression of FBXO32 mRNA CTD PMID:24214992 tetrachloroethene increases expression ISO RGD:737552 6480464 Tetrachloroethylene results in increased expression of FBXO32 mRNA CTD PMID:28973375 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of FBXO32 mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of FBXO32 mRNA CTD PMID:31150632 thapsigargin increases expression ISO RGD:734419 6480464 Thapsigargin results in increased expression of FBXO32 mRNA CTD PMID:22378314 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of FBXO32 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:737552 6480464 titanium dioxide results in increased expression of FBXO32 mRNA CTD PMID:23557971 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of FBXO32 mRNA CTD PMID:33387578 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of FBXO32 mRNA CTD PMID:21515302 tungsten decreases expression ISO RGD:737552 6480464 Tungsten results in decreased expression of FBXO32 mRNA CTD PMID:30912803 tunicamycin increases expression ISO RGD:734419 6480464 Tunicamycin results in increased expression of FBXO32 mRNA CTD PMID:22378314 urethane increases expression ISO RGD:734419 6480464 Urethane results in increased expression of FBXO32 mRNA CTD PMID:28818685 valproic acid increases expression ISO RGD:734419 6480464 Valproic Acid results in increased expression of FBXO32 mRNA CTD PMID:28001369 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of FBXO32 mRNA CTD PMID:23034163 XAV939 multiple interactions ISO RGD:734419 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FBXO32 mRNA, [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FBXO32 mRNA CTD PMID:34480604 zinc atom multiple interactions ISO RGD:734419 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of FBXO32 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:734419 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of FBXO32 mRNA CTD PMID:18593933
